Pipeline: Presbyopia treatment to finish Phase 3 late 2021

Video
Conference|Vision Expo East

Orasis Pharmaceuticals drop in development for treating presbyopia

Orasis Pharmaceuticals CEO Elad Kedar says the company is looking to achieve a balance of safety, efficacy, and comfort with its drop in development for treating presbyopia. He says Phase 3 studies should finish at the end of 2021.

Recent Videos
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, discusses diagnostic confusion that can be encountered when identifying macular edema in patients.
ODs share what they learned at this year's Academy meeting and what they plan to take home to their practices.
Dana Shannon, OD, FAAO, details The Contact Lens Instiute's latest report, The Dropout Dilemma.
Billy R. Hammond details the study, which explored how HEV-light filtering, specifically in the 380-440 nanometer range, impacts visual comfort for patients with presbyopia.
Steve Ferrucci, OD, FAAO, discussed the detection and treatment of geographic atrophy during his AAOpt 2024 lecture, "Imaging Techniques and Emerging Therapies for Geographic Atrophy."
Ahmad Fahmy at AAOpt on neurotrophic pain in OSD
Jamie Kuzniar, OD, FAAO, FSLS, overviews the basics on what to look out for complications-wise in corneal transplant patients that may require a referral.
Dr. Lisa Hornick goes over cosmetic habits and digital eye strain factors in OSD
Brooke Messer, OD, FAAO, FSLS, overviews a talk on keratoconus management.
Related Content
Contact lenses demonstrated to patient Image credit: AdobeStock/Svitlana

AAOpt 2024: Alcon launches first ever one-week replacement contact lens, PRECISION7

Jordana Joy, Associate Editor
November 7th 2024
Article
Practical management EP 14: Your practice-purchase checklist

Practical management EP 14: Your practice-purchase checklist

Maria Sampalis, OD;Kassi Jackson Filkins, Editor
April 27th 2023
Podcast
AAOpt heads to Indianapolis for 2024 meeting - ©tuaindeed

AAOpt 2024: Start your engines!

Lynda Charters
October 28th 2024
Article
Jill Saxon, OD, executive director of professional strategy at Bausch + Lomb

Community care: Connecting mentorship and representation

Emily Kaiser Maharjan, Assistant Managing Editor
April 26th 2023
Podcast
Orasis Pharmaceuticals secures financing for presbyopia-correcting drops Qlosi - ©frankenphoto

Orasis Pharmaceuticals secures financing for commercial launch of presbyopia-correcting drops

Emily Kaiser Maharjan, Assistant Managing Editor
October 9th 2024
Article
Odyssey IOL packaging Image credit: Johnson & Johnson

Johnson & Johnson announces US launch of TECNIS Odyssey IOL

Martin David Harp, Associate Editor, Ophthalmology Times
October 4th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.